Literature DB >> 21189116

Cancer stem cells switch on tumor neovascularization.

Y-F Ping1, X-W Bian.   

Abstract

Recent studies on cancer stem cells (CSCs), a special subpopulation of tumor cells, promote our understanding of tumorigenesis, neovascularization, invasion, drug resistance and tumor recurrence, which establishes new concepts for cancer diagnosis and treatment. Therefore, the biological features and behaviors of CSCs have become an exciting frontier of cancer research. CSCs initiate tumor neovascularization and promote invasion with yet to be defined mechanisms. In this review, we provide evidence for the role of CSCs in tumor vascularization and discuss the potential mechanisms and therapeutic significance based on the interaction between CSCs and their vascular niches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21189116     DOI: 10.2174/156652411794474383

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  7 in total

Review 1.  Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.

Authors:  Xiao-hong Yao; Ying Liu; Keqiang Chen; Wanghua Gong; Ming-yong Liu; Xiu-wu Bian; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-09-17       Impact factor: 4.932

2.  Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo; Jiang F Zhong; William G Loudon
Journal:  World J Stem Cells       Date:  2011-09-26       Impact factor: 5.326

Review 3.  Contribution of cancer stem cells to tumor vasculogenic mimicry.

Authors:  Xiao-hong Yao; Yi-fang Ping; Xiu-wu Bian
Journal:  Protein Cell       Date:  2011-04-29       Impact factor: 14.870

4.  IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.

Authors:  Y Liu; F Li; Y T Yang; X D Xu; J S Chen; T L Chen; H J Chen; Y B Zhu; J Y Lin; Y Li; X M Xie; X L Sun; Y Q Ke
Journal:  Oncogene       Date:  2018-10-27       Impact factor: 9.867

5.  Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry.

Authors:  Samira Derakhshan; Nazanin Mahdavi; Neda Kardouni Khoozestani; Bita Nasr Esfahani; Foroozan Heidarian; Sedigheh Rahrotaban; Ali Abdolrahmani
Journal:  BMC Oral Health       Date:  2022-07-19       Impact factor: 3.747

6.  Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.

Authors:  Xiaohong Yao; Yifang Ping; Ying Liu; Kequiang Chen; Teizo Yoshimura; Mingyong Liu; Wanghua Gong; Chong Chen; Qin Niu; Deyu Guo; Xia Zhang; Ji Ming Wang; Xiuwu Bian
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

7.  WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.

Authors:  Nathalie Ferrand; Aude Fert; Romain Morichon; Nina Radosevic-Robin; Maurice Zaoui; Michèle Sabbah
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.